ReShape Lifesciences Inc Net Asset Quality Index
ReShape Lifesciences Inc net asset quality index. ReShape Lifesciences Inc (RSLS) has a Net Asset Quality Index of 64.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $9.03 Million minus total liabilities of $3.20 Million yields net assets of $5.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of ReShape Lifesciences Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ReShape Lifesciences Inc (2003–2024)
Net asset quality index of ReShape Lifesciences Inc from 2003 to 2024. This chart shows how ReShape Lifesciences Inc's Net Asset Quality Index has evolved across 21 annual periods from 2003 to 2024. As of June 2025, the index stands at 64.6%, representing net assets of $5.83 Million against total assets of $9.03 Million USD. Check how strategically is ReShape Lifesciences Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
ReShape Lifesciences Inc Net Asset Quality Index by Year (2003–2024)
ReShape Lifesciences Inc net asset quality index by year from 2003 to 2024. The table below presents the year-by-year Net Asset Quality Index for ReShape Lifesciences Inc from 2003 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ReShape Lifesciences Inc (RSLS) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -5.3% | $-253.00K | $4.79 Million | $5.05 Million | ▼ -67.8 pp |
| 2023 | 62.5% | $6.66 Million | $10.66 Million | $4.00 Million | ▲ +29.6 pp |
| 2022 | 32.9% | $3.66 Million | $11.14 Million | $7.48 Million | ▼ -52.1 pp |
| 2021 | 84.9% | $46.07 Million | $54.26 Million | $8.19 Million | ▲ +45.8 pp |
| 2020 | 39.1% | $14.49 Million | $37.06 Million | $22.57 Million | ▼ -21.7 pp |
| 2019 | 60.8% | $24.11 Million | $39.66 Million | $15.55 Million | ▼ -7.6 pp |
| 2018 | 68.4% | $31.66 Million | $46.27 Million | $14.61 Million | ▼ -17.7 pp |
| 2017 | 86.1% | $76.37 Million | $88.70 Million | $12.34 Million | ▲ +44.3 pp |
| 2016 | 41.7% | $2.94 Million | $7.04 Million | $4.10 Million | ▲ +10.0 pp |
| 2015 | 31.7% | $3.67 Million | $11.59 Million | $7.91 Million | ▼ -14.6 pp |
| 2014 | 46.3% | $6.66 Million | $14.39 Million | $7.72 Million | ▼ -9.3 pp |
| 2013 | 55.6% | $14.68 Million | $26.39 Million | $11.71 Million | ▲ +10.1 pp |
| 2012 | 45.5% | $11.88 Million | $26.10 Million | $14.22 Million | ▼ -16.2 pp |
| 2011 | 61.7% | $20.04 Million | $32.49 Million | $12.44 Million | ▼ -15.1 pp |
| 2010 | 76.8% | $29.71 Million | $38.69 Million | $8.98 Million | ▲ +42.4 pp |
| 2009 | 34.4% | $5.58 Million | $16.21 Million | $10.63 Million | ▼ -5.9 pp |
| 2008 | 40.3% | $11.41 Million | $28.28 Million | $16.87 Million | ▼ -36.4 pp |
| 2007 | 76.7% | $45.28 Million | $59.05 Million | $13.77 Million | ▼ -2.5 pp |
| 2006 | 79.2% | $28.57 Million | $36.06 Million | $7.49 Million | ▲ +62.2 pp |
| 2005 | 17.1% | $1.97 Million | $11.56 Million | $9.59 Million | ▲ +110.5 pp |
| 2003 | -93.4% | $-670.00K | $717.00K | $1.39 Million | — |